RxDoctor Payments Data

Adam Luginbuhl, MD

Otolaryngology · Philadelphia, PANPI 1811106008

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.7%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.2% of the total. Reporting peaked in 2023 at $1,360 and has fallen 67.2% since, to $446 in 2024.

$2,678in general payments, 2019–2025

Across 29 payments — averaging $92.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Intuitive Surgical$567
  • Isoray, Inc$210
  • Galvanize Therapeutics, Inc$168
  • Baxter Healthcare$148
  • Johnson & Johnson$89
  • plus $180 from 3 others
$742,341in research payments, 2019–2025

Across 22 payments — averaging $33,743 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$498K
  • Hoffmann-la Roche Limited$244K
  • E.r. Squibb & Sons, L.L.C.$217

What the payments were for

  • Travel & lodging$1,54458%
  • Food & beverage$1,00938%
  • Entertainment$1255%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,678 in reported general payments places this provider in the 70th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$215,827
Medicare patients
334
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone16$77

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →